Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Breast Cancer"
DOI: 10.1016/j.clbc.2018.07.006
Abstract: The efficacy and safety of palbociclib, a cyclindependent kinase 4/6 inhibitor, used in combination with fulvestrant was assessed in women with advanced breast cancer (ABC) whose disease had progressed during previous endocrine therapy, with a…
read more here.
Keywords:
leukocytoclastic vasculitis;
cutaneous gastrointestinal;
case;
breast cancer ... See more keywords